Genae buys regulatory affairs company MedicSense

Medical device contract research provider Genae (Antwerp, Belgium) recently acquired MedicSense, a clinical, regulatory affairs and quality assurance consultancy firm based in Tel Aviv, Israel. Terms were not disclosed.

“The vast regulatory and quality assurance expertise of the MedicSense team represents a logical expansion of Genae’s value chain of services,” said Genae CEO Bart Segers in a prepared statement. “Being involved in the early stages of the development process lowers the risk of potential re-engineering and accelerates the time to market, while remaining in compliance with worldwide regulatory requirements.”

“Integrating MedicSense in the Genae group addresses the needs of the vibrant, high-tech medical device industry and the dynamic regulatory environment,” added MedicSense co-founders and CEOs Adi Ickowicz and Erez Adiv. “This approach favors the entire service industry and represents a major advantage for the larger multi-disciplinary and more comprehensive service providers.”

MedicSense has been in business for more than 20 years, developing dedicated regulatory strategies, from initial product registration to post-marketing activities. Genae works with companies worldwide on developing devices and therapies. It acquired the digital health data management platform Hilbert Paradox in March 2018.

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW